153 related articles for article (PubMed ID: 18268124)
1. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.
Sellers TA; Huang Y; Cunningham J; Goode EL; Sutphen R; Vierkant RA; Kelemen LE; Fredericksen ZS; Liebow M; Pankratz VS; Hartmann LC; Myer J; Iversen ES; Schildkraut JM; Phelan C
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):397-404. PubMed ID: 18268124
[TBL] [Abstract][Full Text] [Related]
2. Estrogen bioactivation, genetic polymorphisms, and ovarian cancer.
Sellers TA; Schildkraut JM; Pankratz VS; Vierkant RA; Fredericksen ZS; Olson JE; Cunningham J; Taylor W; Liebow M; McPherson C; Hartmann LC; Pal T; Adjei AA
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2536-43. PubMed ID: 16284375
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
Palmieri RT; Wilson MA; Iversen ES; Clyde MA; Calingaert B; Moorman PG; Poole C; Anderson AR; Anderson S; Anton-Culver H; Beesley J; Hogdall E; Brewster W; Carney ME; Chen X; Chenevix-Trench G; Chang-Claude J; Cunningham JM; Dicioccio RA; Doherty JA; Easton DF; Edlund CK; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Kjaer SK; Hogdall CK; Hopkins MP; Jenison EL; Blaakaer J; Lurie G; McGuire V; Menon U; Moysich KB; Ness RB; Pearce CL; Pharoah PD; Pike MC; Ramus SJ; Rossing MA; Song H; Terada KY; Vandenberg D; Vierkant RA; Wang-Gohrke S; Webb PM; Whittemore AS; Wu AH; Ziogas A; Berchuck A; Schildkraut JM; ; ;
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3567-72. PubMed ID: 19064572
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival.
Williams KA; Terry KL; Tworoger SS; Vitonis AF; Titus LJ; Cramer DW
PLoS One; 2014; 9(2):e88334. PubMed ID: 24551091
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.
Phelan CM; Tsai YY; Goode EL; Vierkant RA; Fridley BL; Beesley J; Chen XQ; Webb PM; Chanock S; Cramer DW; Moysich K; Edwards RP; Chang-Claude J; Garcia-Closas M; Yang H; Wang-Gohrke S; Hein R; Green AC; Lissowska J; Carney ME; Lurie G; Wilkens LR; Ness RB; Pearce CL; Wu AH; Van Den Berg DJ; Stram DO; Terry KL; Whiteman DC; Whittemore AS; DiCioccio RA; McGuire V; Doherty JA; Rossing MA; Anton-Culver H; Ziogas A; Hogdall C; Hogdall E; Krüger Kjaer S; Blaakaer J; Quaye L; Ramus SJ; Jacobs I; Song H; Pharoah PD; Iversen ES; Marks JR; Pike MC; Gayther SA; Cunningham JM; Goodman MT; Schildkraut JM; Chenevix-Trench G; Berchuck A; Sellers TA; ;
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):600-4. PubMed ID: 20142253
[TBL] [Abstract][Full Text] [Related]
6. Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk.
Earp MA; Brooks-Wilson A; Cook L; Le N
BMC Res Notes; 2013 Oct; 6():425. PubMed ID: 24148579
[TBL] [Abstract][Full Text] [Related]
7. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
Goode EL; Fridley BL; Vierkant RA; Cunningham JM; Phelan CM; Anderson S; Rider DN; White KL; Pankratz VS; Song H; Hogdall E; Kjaer SK; Whittemore AS; DiCioccio R; Ramus SJ; Gayther SA; Schildkraut JM; Pharaoh PP; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):935-44. PubMed ID: 19258477
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
Kelemen LE; Sellers TA; Schildkraut JM; Cunningham JM; Vierkant RA; Pankratz VS; Fredericksen ZS; Gadre MK; Rider DN; Liebow M; Goode EL
Cancer Res; 2008 Apr; 68(7):2498-506. PubMed ID: 18381459
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
Grant DJ; Hoyo C; Akushevich L; Iversen ES; Whitaker R; Marks J; Berchuck A; Schildkraut JM
Gynecol Oncol; 2013 Apr; 129(1):173-8. PubMed ID: 23262379
[TBL] [Abstract][Full Text] [Related]
10. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
11. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
12. STK15 polymorphisms and association with risk of invasive ovarian cancer.
Dicioccio RA; Song H; Waterfall C; Kimura MT; Nagase H; McGuire V; Hogdall E; Shah MN; Luben RN; Easton DF; Jacobs IJ; Ponder BA; Whittemore AS; Gayther SA; Pharoah PD; Kruger-Kjaer S
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1589-94. PubMed ID: 15466974
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the progesterone receptor gene and ovarian cancer risk.
Terry KL; De Vivo I; Titus-Ernstoff L; Sluss PM; Cramer DW
Am J Epidemiol; 2005 Mar; 161(5):442-51. PubMed ID: 15718480
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
15. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
16. Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
White KL; Sellers TA; Fridley BL; Vierkant RA; Phelan CM; Tsai YY; Kalli KR; Berchuck A; Iversen ES; Hartmann LC; Liebow M; Armasu S; Fredericksen Z; Larson MC; Duggan D; Couch FJ; Schildkraut JM; Cunningham JM; Goode EL
Twin Res Hum Genet; 2010 Feb; 13(1):43-56. PubMed ID: 20158306
[TBL] [Abstract][Full Text] [Related]
17. Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer.
Kupcinskas J; Gyvyte U; Bruzaite I; Leja M; Kupcinskaite-Noreikiene R; Pauzas H; Tamelis A; Jonaitis L; Skieceviciene J; Kiudelis G
Asian Pac J Cancer Prev; 2015; 16(14):6027-32. PubMed ID: 26320491
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
19. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
[TBL] [Abstract][Full Text] [Related]
20. Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.
Janardhan B; Vaderhobli S; Bhagat R; Chennagiri Srinivasamurthy P; Venketeshiah Reddihalli P; Gawari R; Krishnamoorthy L
PLoS One; 2015; 10(7):e0131190. PubMed ID: 26158818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
